EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A rare presentation of probable catastrophic antiphospholipid syndrome with bilateral adrenal hemorrhage

Jyotirmay Maji, Ajitesh Roy

JCEM Case Reports · 2026-10-16 · 4 (12)

DOI: 10.1210/jcemcr/luag345 ↗
AbstractBibliografische Angaben

Abstract

Abstract Catastrophic antiphospholipid syndrome (APS), a rare thrombotic manifestation of APS, is associated with high mortality. Rarely, it can present with bilateral adrenal hemorrhage (BAH). This case highlights a rare presentation of BAH due to probable catastrophic APS secondary to systemic lupus erythematosus (SLE). A 57-year-old female with diabetes presented with hypovolemic shock, abdominal pain, and vomiting. Imaging revealed BAH; antiphospholipid antibodies were present in high titers in the blood. Antinuclear antibody and antidouble-stranded deoxyribonucleic acid antibody (anti-dsDNA) were positive in high titers. Catastrophic APS secondary to SLE was diagnosed. Serum morning cortisol was at 9.2 μg/dL (SI: 254 nmol/L) (reference range: 5-25 μg/dL [SI: 138-635 nmol/L]), and adrenocorticotropic hormone was at 180 pg/mL (SI: 39.6 pmol/L) (reference range: 10-60 pg/mL [SI: 1.6-13.9 pmol/L]); which indicated evolving primary adrenal insufficiency. The patient received pulse methylprednisolone, intravenous immunoglobulin, anticoagulants, and mycophenolate mofetil. Oral glucocorticoid was continued with regular monitoring of adrenal function. Mineralocorticoid replacement was not needed as the renin–angiotensin–aldosterone system axis was intact. This report contributes to the sparse literature on catastrophic APS-related BAH, highlighting the need for early diagnosis and combined immunosuppressive and anticoagulant treatment.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →